Table 4.
Oxidative burst, phagocytosis and chemotaxis before and after deoxyspergualin (DSG) therapy.
| Patients before and after DSG | Oxidative burst (FI) | Phagocytosis (FI) | Chemotaxis (counts) | |||
|---|---|---|---|---|---|---|
| Neutrophils | Neutrophils | Monocytes | Neutrophils | |||
| fMLP | E. coli | PMA | E. coli | fMLP | ||
| 1 | ||||||
| Before | 50 | 205 | 1297 | 739 | 508 | 6 711 |
| After | 111 | 356 | 1151 | 1034 | 624 | 282 |
| 2 | ||||||
| Before | 105 | 285 | 912 | 1121 | 1010 | 941 |
| After | 207 | 438 | 553 | 1149 | 967 | 526 |
| 3 | ||||||
| Before | 38 | 329 | 520 | 1122 | 640 | 7 573 |
| After | 80 | 295 | 1005 | 842 | 696 | 11 554 |
| 4 | ||||||
| Before | 110 | 286 | 305 | 2092 | 985 | 1 552 |
| After | 61 | 385 | 554 | 1368 | 903 | 2 471 |
| P-value | 0·273 | 0·144 | 0·715 | 0·715 | 0·715 | 1·0 |
FI: fluorescence intensity; fMLP: formylmethionylleucylphenylalanine; PMA: phorbol myristate acetate. P-value: before versus after treatment.